Endometrial thickness in tamoxifen-treated patients: Correlation with clinical and pathologic findings

American Journal of Roentgenology

Volumn 168, Issue 3, 1997, Pages 657-661

  Hann, Lucy E ^a   Giess, Catherine S ^a,b   Bach, Ariadne M ^a   Tao, Yue ^a   Baum, Heather J ^a,c   Barakat, Richard R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 0031053904     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.168.3.9057510     Document Type: Article

References (32)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339:1-15
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339:71-85
3. Boccardo F, Bruzzi P, Rubagotti A, et al. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981;38:281-285
4. Boccardo F, Guarneri D, Rubagotti A, et al. Endocrine effects of tamoxifen in postmenopausal breast cancer patients. Tumori 1984;70:61-68
5. Satyaswaroop PG, Zaino RJ, Mortel R. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 1984;44:4006-4010
6. Gottardis MM, Robinson SP, Satyaswaroop PG, et al. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988;48:812-815
7. Lahti E, Banco G, Kauppila A, et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993;81: 660-664
8. Cohen I, Rosen DJD, Shapira J, et al. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic postmenopausal breast cancer patients. Gynecol Oncol 1994;52:185-190
9. Gal D, Kopel S, Bashevkin M, et al. Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer: preliminary report. Gynecol Oncol 1991;42:120-123
10. Neven P, DeMuylder X, Van Belle Y, et al. Tamoxifen and the uterus and endometrium (letter). Lancet 1989; 1:375
11. Kedar RP, Bourne TH, Powles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994;343:1318-1321
12. DeMuylder X, Neven P, DeSomer M, et al. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 1991;36:127-130
13. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;86:527-537
14. Fornander T, Rutqvist LE, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer occurrence of new primary cancers. Lancet 1989;1:117-120
15. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 1994;170:447-451
16. Exacoustos C, Zupi E, Cangi B, Chiaretti M, Arduini D, Romanini C. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 1995;6:435-442
17. Achiron R. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 1995; 14:685-688
18. Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 1996;77:2058-2063
19. Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR 1993;160:809-812
20. Cohen I, Rosen DJD, Tepper R, et al. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993;5:275-280
21. Tepper R, Cohen I, Altros M, et al. Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. J Ultrasound Med 1994;13:635-640
22. Lin MC, Gosink BB, Wolf SI, et al. Endometrial thickness after menopause: effect of hormone replacement. Radiology 1991;180:427-432
23. Currie JL. US monitoring of endometrial thickness in estrogen replacement therapy (editorial). Radiology 1991;180:306
24. Dubinsky TJ, Parvey R, Gormaz G, Curtis M, Maklud N. Transvaginal hysterosonography: comparison with biopsy in the evaluation of postmenopausal bleeding. J Ultrasound Med 1995;14:887-893
25. Cullinan JA, Fleischer AC, Kepple DM, Arnold AL. Sonohysterography: technique for endometrial evaluation. RadioGraphics 1995;15:501-514
26. Magriples U, Naftolin F, Schwartz PE, et al. Highgrade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993;11:485-490
27. Barakat RR, Wong G, Curtin JP, et al. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 1994;55:164-168
28. Van Leeuwen FE, Benraadt J, Coebergh JWW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994;343:448-452
29. Gibson LE, Barakat RR, Venkatraman ES, et al. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers. Cancer J Sci Am 1996;2:35-38
30. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 1990;163:119-123
31. Uziely B, Lewin A, Brufman G, et al. The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 1993;26:101-105
32. Cohen I, Tepper R, Rosen DJD, et al. Continuous tamoxifen treatment in asymptomatic postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 1994;55:138-143